Anthony R. Hunter

From Infogalactic: the planetary knowledge core
(Redirected from Tony Hunter)
Jump to: navigation, search

<templatestyles src="Module:Hatnote/styles.css"></templatestyles>

Tony Hunter
300px
Anthony Rex Hunter
Born Anthony Rex Hunter
(1943-08-23) 23 August 1943 (age 80)
United Kingdom
Nationality British
Fields Biology
Institutions <templatestyles src="Plainlist/styles.css"/>
Alma mater <templatestyles src="Plainlist/styles.css"/>
Thesis Aspects of mammalian protein synthesis (1969)
Notable students Jonathon Pines (postdoc)[1][2][3]
Known for Kinases[4]
Notable awards <templatestyles src="Plainlist/styles.css"/>
Website
www.salk.edu/scientist/tony-hunter/

Anthony Rex Hunter (born 23 August 1943) is a British-American biologist who is a Professor of Biology at the Salk Institute for Biological Studies and the University of California, San Diego. His research publications list his name as Tony Hunter.[5]

Early life and Education

Hunter was born in 1943 in the United Kingdom and educated at Felsted School, prior to Christ's College, Cambridge where he was awarded a PhD in 1969 for research on protein synthesis.[6]

Career and research

Following his PhD, Hunter held a fellowship at Christ's College, Cambridge in Cambridge (1968–1971) and (1973–1975). From 1971 to 1973, he was a postdoctoral research associate of the Salk Institute for Biological Studies in La Jolla, California. He was then assistant professor 1975–78, associate professor 1978–82, professor 1982 onwards and since 2008 director of the Salk Institute Cancer Center.[7] He also sits on the Selection Committee for Life Science and Medicine which chooses winners of the Shaw Prize.

Hunter is one of the foremost recognized leaders in the field of cell growth control, growth factor receptors and their signal transduction pathways. He is well known for discovering that tyrosine phosphorylation is a fundamental mechanism for transmembrane-signal transduction in response to growth factor stimulation and that disregulation of such tyrosine phosphorylation, by activated oncogenic protein tyrosine kinases,[4] is a pivotal mechanism utilized in the malignant transformation of cells. His work is important in signaling pathways and their disorders.

Hunter was a founder of Signal Pharmaceuticals.[citation needed]

Awards and honors

He won the Wolf Prize in Medicine in 2005 for "the discovery of protein kinases that phosphorylate tyrosine residues in proteins, critical for the regulation of a wide variety of cellular events, including malignant transformation".[8] He has been granted along with Charles Sawyers and Joseph Schlessinger with the 2014 BBVA Foundation Frontiers of Knowledge Award in the Biomedicine category for “carving out the path that led to the development of a new class of successful cancer drugs.”

References

  1. Lua error in package.lua at line 80: module 'strict' not found.
  2. Lua error in package.lua at line 80: module 'strict' not found.
  3. Lua error in package.lua at line 80: module 'strict' not found.
  4. 4.0 4.1 Lua error in package.lua at line 80: module 'strict' not found.
  5. Lua error in package.lua at line 80: module 'strict' not found.
  6. Lua error in package.lua at line 80: module 'strict' not found.
  7. Lua error in package.lua at line 80: module 'strict' not found.
  8. The Wolf Prize in Medicine at the Wayback Machine (archived February 26, 2009). wolffund.org.il
  9. Lua error in package.lua at line 80: module 'strict' not found.
  10. The Keio Medical Science Prize. Ms-fund.keio.ac.jp. Retrieved on 2013-10-08.
  11. Tony Hunter at The Salk Institute. Biology.ucsd.edu. Retrieved on 2013-10-08.
  12. Tony Hunter Receives Pasarow Award for Cancer Research. Salk Institute for Biological Studies (2011)
  13. PNAS Member Editor Details. Nrc88.nas.edu. Retrieved on 2013-10-08.